Virtually all immunoglobulin kappa (IGK) gene deletions are mediated via rearrangements of the so-called kappa deleting element (Kde).
Introduction
The various types of B-lineage leukemias, ie precursor-B-acute lymphoblastic leukemias (ALL) and chronic B cell leukemias are regarded as malignant counterparts of immature and mature B cells, respectively. [1] [2] [3] [4] [5] Based on leukemia studies, it has been found that immunoglobulin (Ig) gene rearrangements occur in sequential order: Ig heavy-chain (IGH) genes rearrange first, followed by Ig kappa (IGK) gene rearrangements, which precede Ig lambda (IGL) gene rearrangements. [2] [3] [4] [5] [6] IGL gene rearrangements occur after or coincide with IGK gene deletions, which involve deletion of J and/or C gene segments. 6, 7 The vast majority (Ͼ98%) of IGK gene deletions are mediated via site-specific rearrangements of the kappa deleting element (Kde), which is located approximately 24 kb downstream of the C gene segment. [7] [8] [9] [10] [11] Kde rearranges via its heptamer-nonamer recombination signal sequence (RSS) either to the heptamer RSS located in the J-C intron (intron RSS), resulting in C deletions, or to the heptamer-nonamer RSS at the 3Ј side of a V gene segment, resulting in J-C deletions ( Figure 1 ). [7] [8] [9] [10] [11] In principle V-Kde rearrangements can involve any of the approximately 76 V gene segments, 12, 13 which are located either adjacent to the J-C region (indicated as proximal) or located further upstream from the J-C region in an inverted orientation (indicated as 12 Sequence information used to design primers for VIV, VV, VVI and VVII primers were derived from Refs 36-39. The J-C intron and Kde primers were developed according to sequences described in Refs 8 and 40. a The position of the 3Ј side of the primers is indicated upstream (+) or downstream (−) of the closest RSS. In case of the IgRS (intron) primers the position is indicated relative to the heptamer RSS in the J-C intron sequence. b The application of the primers is indicated: PCR, primer for PCR amplification; SEQ, primer for sequencing. distal).
14 The V gene segments are clustered in seven families on the basis of sequence homology. 12, 13 Comparable to V-(D-)J rearrangements, [15] [16] [17] [18] the Kde rearrangements probably also result in junctional regions with deletion of nucleotides by trimming of the gene involved segments, 19 P-region nucleotides, 20 and N-region nucleotides.
18-21 P-region nucleotides are template dependent, whereas N-nucleotides are randomly inserted at junctions by the enzyme terminal deoxynucleotidyl transferase (TdT). [18] [19] [20] [21] Junctional regions of rearranged IGH, T cell receptor gamma (TCRG), and T cell receptor delta (TCRD) genes are being used as targets for detection of minimal residual disease (MRD) in ALL by use of the polymerase chain reaction (PCR) technique. [22] [23] [24] [25] [26] However, it should be noted that the applicability of these patient-specific sequences as targets for the MRD-PCR technique is dependent on the occurrence, sensitivity and stability of the involved Ig/TCR gene rearrangements. 4, [26] [27] [28] [29] [30] [31] [32] [33] So far, junctional regions of rearranged Ig light chain genes have not been evaluated as MRD-PCR targets in ALL, because initial reports suggested that IGK and IGL gene rearrangements occur at low frequency in ALL (approximately 20%) and because it was assumed that the junctional diversity of rearranged IGK and IGL genes is restricted as observed in normal blood B-lymphocytes. 2, 34 The aim of our study was to obtain more detailed information about Kde rearrangements during B cell differentiation. Therefore, we examined the junctional regions of V-Kde rearrangements and intron RSS-Kde rearrangements in a large series of 130 immature and mature B-lineage leukemias. Furthermore, we evaluated the applicability of the Kde rearrangements as MRD-PCR targets in precursor-B-ALL.
Materials and methods

Cell samples
A large group of 130 B-lineage leukemias was selected based on the presence of Kde rearrangements as detected by Southern blotting in previous studies. 4, 11 This group of leukemias comprised 63 precursor-B-ALL (one pro-B-ALL, 41 common-ALL, and 21 pre-B-ALL) and 67 chronic B cell leukemias (58 chronic lymphocytic leukemias (CLL), five prolymphocytic leukemias (PLL), and four hairy cell leukemias (HCL)).
Mononuclear cells (MNC) were obtained from peripheral blood (PB) or bone marrow (BM) samples of the 130 B-lineage leukemias, as well as from PB of some healthy adult controls by Ficoll-Paque centrifugation (density: 1.077 g/cm 3 ; Pharmacia, Uppsala, Sweden). All MNC samples were frozen and stored in liquid nitrogen. The cell samples were obtained according to the guidelines of the Medical Ethics Committee of the University Hospital Rotterdam/Erasmus University Rotterdam.
DNA was isolated from MNC samples as described previously. 16, 35 PCR analysis PCR amplification was performed as described previously. A mixture of 1.0 g DNA, 12.5 pmol of the upstream and downstream oligonucleotide primers (Table 1) , and 1 unit of AmpliTaq DNA polymerase (Perkin-Elmer, Norwalk, CT, USA) were used in each PCR of 100 l. The primers were designed according to known sequence data 8, 12, [36] [37] [38] [39] [40] and carefully positioned, resulting in PCR products for optimal analysis of junctional regions of Kde rearrangements, by using either V family primers or the intron RSS primer (IgRS) in combination with a Kde primer. The PCR reaction mixture was heated at 92°C for 3 min in a thermal cycler (Perkin-Elmer), followed by 35 cycles of denaturation, annealing and extension at 92°C for 45 s, at 60°C for 90 s, and at 72°C for 2 min, respectively. After the last cycle an additional extension step at 72°C for 10 min was performed.
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Selected series of junctional regions of Kde rearrangements. Sequences of the junctional regions of Kde rearrangements are aligned with the known V family germline sequences (N, any nucleotide), with the germline sequence of the J-C intron, and with the Kde germline sequence (double underlined). In the left column V gene segment codes are indicated with the family number in brackets. In the right column the patient/case registration numbers are given. Lower case characters at the end of a junctional region represent P-region nucleotides. All other nucleotides at the junctional region represent N-region nucleotides. The used patient-specific oligonucleotide probes for hybridization analysis are indicated (underlined). (14) 19 (29%) 5 (13%) VIII (8) 17
Number of V gene segments belonging to a V family which are potentially functional or have minor defects but still have the potential to become functional due to mutations. 12,13 b The data are based on 66 V-Kde rearrangements in precursor-B-ALL, detected by Southern blot analysis 11 and confirmed by heteroduplex PCR analysis or sequencing. The data are based on 38 V-Kde rearrangements in chronic B cell leukemias, detected by Southern blot analysis 11 and confirmed by heteroduplex PCR analysis or sequencing.
Heteroduplex PCR analysis PCR products were denatured for 5 min at 94°C. After denaturation, the samples were rapidly cooled down to 4°C and incubated for at least 60 min at this temperature. Size separation of the generated homoduplexes and heteroduplexes was obtained in a 6% non-denaturing polyacrylamide gel. 41 
Sequencing analysis
Junctional region sequences were either obtained with the T7-sequencing kit (Pharmacia) using 35 S radiolabeling (46 Kde rearrangements) or by direct cycle sequencing using fluorescently labeled dideoxynucleotides (Perkin-Elmer) (63 Kde rearrangements). The sequence reactions were performed using sequence primers (Table 1) following the manufacturer's instructions. The junctional region of each Kde rearrangement was sequenced twice, starting from two independent PCR reactions and from opposite sequence directions.
To obtain single-stranded PCR products for radioactive sequencing, asymmetric PCR reactions were performed using 12 pmol of the limiting primer and 600 pmol of the opposite primer followed by two consecutive 50% ethanol extractions. Subsequently, T7-sequencing was carried out using 50 pmol of the sequence primer and products were run in a denaturing 8% polyacrylamide gel.
For direct cycle sequencing excised homoduplex bands were used that were generated by heteroduplex analysis of the initial PCR product. DNA was eluted from gel fragments by incubation at 37°C for approximately 20 h in 0.5 m ammonium acetate, 10 mm magnesium acetate, 1 mm EDTA (pH 8.0), and 0.1% SDS and precipitated using 0.1 volumes 2 m sodium acetate pH 5.6, and 2 volumes 96% ethanol. Sequence reactions were carried out with 10 pmol primer and an annealing temperature of 50°C and analyzed using the ABI 373 sequencer (Perkin-Elmer, Applied Biosystems Division).
Specificity and sensitivity of Kde rearrangements as PCR targets
To determine the specificity of junctional regions, PCR-amplified Kde rearrangements were size-separated in 1.0% agarose gels, transferred to 0.45 m Nytran-13N nylon membranes (Schleicher and Schuell, Dassel, Germany), and UV crosslinked as described. 16, 35 Subsequently, the nylon membranes were hybridized with ␥-32 P-dATP 5Ј end-labeled junctional region oligonucleotide probes, designed according to the obtained sequence information. Hybridizations were performed at 50°C for 2 h in a hybridization buffer containing 3 × SSC, 1% SDS, 10% Dextran sulphate, and 10 × Denhardt's solution.
DNA dilution experiments were performed to determine the MRD-PCR sensitivity of Kde rearrangements. DNA from precursor-B-ALL patients containing either V-Kde or intron RSSKde rearrangements were diluted into control PB-MNC DNA from healthy adult individuals. The dilution steps were down to 10 −7 of patient DNA into control DNA. After PCR analysis, 5 l of the PCR products obtained was spotted in duplicate onto nylon membranes, UV cross-linked, and hybridized with junctional region probes as described above.
Results
PCR, heteroduplex and sequencing analysis of Kde rearrangements
In all 130 selected B-lineage leukemia cases, the Southern blot data could be confirmed by PCR analysis of the two types of Kde rearrangements with the designed oligonucleotide primers (Table 1) . A total of 189 Kde rearrangements were identified: 87 in 63 precursor-B-ALL and 102 in 67 chronic B cell leukemias. Heteroduplex analysis appeared to be a powerful tool in discrimination between monoallelic and biallelic rearrangements as well as between monoclonal and polyclonal rearrangements. V gene segment usage in B-lineage leukemias V-Kde rearrangements represented approximately 75% of Kde rearrangements in precursor-B-ALL and approximately 45% in chronic B cell leukemias. 11 The usage of the different V families determined by PCR analysis is summarized in Table 2 . VI family members are more frequently used (approximately 50%) in V-Kde rearrangements in chronic B cell leukemias, whereas the V-Kde rearrangements in precursor-B-ALL utilized the VI, VII, and VIII family members in comparable frequencies (35, 29 and 26%, respectively). Kde rearrangements to the VV and VVI families were rare. Interestingly, the single member VVII family was used in 5/66 (7%) precursor-B-ALL (Table 2 ).
All V gene segment sequences obtained by (direct) sequence analysis of V-Kde rearrangements, had significant homology to known germline sequences. 12, 13 When examined, proximal V gene segments were used in the majority of V-Kde rearrangements in precursor-B-ALL and chronic B cell leukemias. Privileged V family members in precursor-B- 
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The diversity of the Kde rearrangement junctional regions allows patient-specific hybridization. PCR products of Kde rearrangements to either intron RSS (A) or to V gene segments (B) from several precursor-B-ALL patients and normal BM and PB were run in an agarose gel and subsequently blotted. The filters were successively hybridized with four patient-specific oligonucleotide probes (underlined in Figure 2 ), which exclusively recognized the corresponding PCR products.
ALL were L1, L9 and A30 (VI), A17 (VII), A27 (VIII), and B1 (VVII). In chronic B cell leukemias no family member was used preferentially. Junctional regions of Kde rearrangements Table 3 summarizes the characteristics of the junctional region sequences of Kde rearrangements in B-lineage leukemias. The sizes of the junctional regions differed from 0 to maximally 30 nucleotides with an average of 4.7 nucleotides in the precursor-B-ALL group. In the chronic B cell leukemia group the sizes of the junctional regions differed from 0 to maximally nine nucleotides with an average of 1.9 nucleotides. In a large part of V-Kde rearrangements, no randomly inserted N-region nucleotides were found in chronic B cell leukemias (Figure 2 ), but more inserted nucleotides (mean, 2.2) and trimming of nucleotides (mean, 6.8) were found in the junctional regions of intron RSS-Kde rearrangements (Table 3) .
Specificity of patient-specific oligonucleotide probes and primers
To determine the specificity of the patient-specific oligonucleotide probes, the Kde rearrangement PCR products of several patient DNA samples were size-separated, blotted and successively hybridized with four patient-specific oligonucleotide probes ( Figure 3) . In all cases, the patient-specific oligonucleotide probes detected the corresponding patient-derived PCR products exclusively. In addition, positive hybridization signals were not detected in either normal BM or normal PB (Figure 3 ). , whereas a VII-Kde rearrangement with five deleted and three inserted nucleotides had a sensitivity of 10 −6 ( Figure 4 ).
Discussion
Until recently, only a few studies about V gene usage in IGK gene rearrangements in normal and malignant (precursor) B cells were reported. [42] [43] [44] [45] [46] But with the discovery of the PCR technique the analysis of antigen specific receptor gene rearrangements as well as the analysis of IGK gene rearrangements is moving rapidly. [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] However, reports about V gene usage in Kde rearrangements are not available. V family usage (VI-IV) in our Kde rearrangements was compared with V family usage in V-J rearrangements as reported in the literature and summarized in Table 4 . 42, 45, 46, 54, 55 This comparison revealed that V family usage in V-J gene rearrangements and V-Kde rearrangements is comparable except for a higher tendency of VII family usage in V-Kde gene rearrangements of precursor-B-ALL. The most frequently used V gene segments of each V family found in V-J gene rearrangements are also frequently used in V-Kde gene rearrangements. [48] [49] [50] 54, 55 Distal V gene segments are rarely used in V-Kde gene rearrangements. Apparently, the usage of V gene segments is not clearly dependent on the type of rearrangement (V-J or V-Kde), but particular V gene segments (eg VI family, L1, L9, and A30; VII family, A17; and VIII family, A27) are probably more prone to rearrange than other V gene segments.
Sequence analysis of the Kde rearrangements revealed a striking difference in junctional region diversity between precursor-B-ALL and chronic B cell leukemias ( Figure 2 and Table 2 ). Two to three times more insertion of N-region nucleotides and deletion of nucleotides was found in the junctional regions of Kde rearrangements in precursor-B-ALL as compared to chronic B cell leukemias, but trimming of nucleotides in intron RSS-Kde rearrangements was comparable. Apparently, TdT is still active in precursor-B-ALL at the time Kde rearrangements take place, whereas in chronic B cell leukemias TdT activity is decreased or absent at the time of Kde rearrangements. The latter is in line with the small junctional regions of V-J rearrangements (average insertion: 1-2 nucleotides) in normal B-lymphocytes. 34, [47] [48] [49] [50] [51] [52] This is confirmed by the finding that normal precursor-B cells rearrange Ig genes at the same time as they undergo V H to D-J rearrangements, which do not contain much N-region diversity (average Ͻ1 nucleotides). 34 We hypothesize that the continuous recombinase and TdT activity in precursor-B-ALL cells, [56] [57] [58] cause the frequently occurring continuing gene rearrangements, [27] [28] [29] [30] [31] [32] [33] including the high frequency of IGK gene rearrangements and deletions, 11 and the relatively large Nregions in Kde rearrangements (Figure 2) .
Detection of MRD by use of the PCR technique is a powerful tool for monitoring leukemic cells during and after treatment, because these techniques are potentially able to detect low frequencies of leukemic cells down to 10 −4 -10 −6 . 26 The applicability of the MRD-PCR technique is dependent on the presence of suitable targets and on the detection limit of the technique, which is influenced by the occurrence of the involved MRD-PCR target in normal cells. IGH, TCRG, and TCRD gene rearrangements are the most commonly used MRD-PCR targets in ALL patients. [22] [23] [24] [25] [26] However, these three types of MRD-PCR targets might not be stable during the disease process due to continuing rearrangements or secondary rearrangements, 4,27-33 which will lead to false negative results. In this study, we investigated the applicability of Kde rearrangements as new MRD-PCR target in precursor-B-ALL.
Kde rearrangements occur in half of the precursor-B-ALL cases, in 28% on one allele and in 23% on both alleles. (Figure 4 ). Furthermore, it should be noted that Kde rearrangements are 'end-stage' rearrangements, which cannot undergo further rearrangements. 7, 10, 11 Therefore, Kde rearrangements are likely to remain stable during the disease course, which is in contrast to IGH, TCRG and TCRD gene rearrangements in ALL. [27] [28] [29] [30] [31] [32] [33] This implies that the chance of false-negative MRD-PCR results will probably be very low.
In conclusion, our data indicate that Kde rearrangements represent valuable patient-specific PCR targets, which can be used for detection of MRD in approximately 50% of precursor-B-ALL patients. In the meantime, this PCR target has been included in the ongoing collaborative MRD study in childhood ALL of the International BFM Study Group. seeuw-Appel, CG Tromp, M van Marwijk Kooy, WE Terpstra, MB van 't Veer and GE van Zanen are thanked for collecting the cell samples of acute and chronic leukemia patients 
Figure 4
Dilution experiment in which DNA from a precursor-B-ALL patient with a VII-Kde rearrangement was diluted in PB-MNC DNA from a healthy individual. PCR products obtained after amplification with the VII-5Ј and Kde-3Ј primers were directly spotted in duplicate to a nylon membrane, which was hybridized with the 32 Plabeled patient-specific junctional region probe. Leukemia-derived PCR products were detectable down to the approximately 10 −6 dilution mixture despite the short junctional region.
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